Close Menu
    What's Hot

    UK Pension Risk Transfer Market Set to Hit £70bn in 2026

    February 10, 2026

    Deloitte UK Pension Schemes Completes Bulk Purchase Annuity Buy-In With Standard Life

    February 10, 2026

    Trustee of Vistry’s Final Salary Pension Schemes Completes Bulk Purchase Annuity Buy-In With PIC

    February 10, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      Reporting Change to Provide Regulators With More Transparency into US/Offshore Asset-Intensive Life Reinsurance Treaties

      January 28, 2026

      Capital Markets Investors Could Be About to Get a Slice of UK Life Insurance Risk

      November 26, 2025

      Tailwinds and Structural Strength Support Sustainable — If Moderating — US Life & Annuity Market Growth

      November 12, 2025

      US Annuity Sales Set Yet Another Quarterly Sales Record in Third Quarter of 2025

      October 30, 2025

      10 Areas To Watch for AI Innovation in Life and Health Underwriting and Claims

      January 28, 2026

      Lewis & Ellis and Griffith, Ballard & Company Expand Life Insurance Capabilities Through Strategic Partnership

      January 21, 2026

      Stability Continues in US Life Insurer Ownership and Solvency Metrics

      January 14, 2026

      Third Quarter Sets New US Annuity Sales Record

      December 10, 2025

      UK Pension Risk Transfer Market Set to Hit £70bn in 2026

      February 10, 2026

      Deloitte UK Pension Schemes Completes Bulk Purchase Annuity Buy-In With Standard Life

      February 10, 2026

      Trustee of Vistry’s Final Salary Pension Schemes Completes Bulk Purchase Annuity Buy-In With PIC

      February 10, 2026

      The Argent Group Europe Pension Scheme Secures Full Scheme Bulk Purchase Annuity Buy-In With Just Group

      February 9, 2026

      CMI Model Changes and Weight-Loss Drug Popularity Point to Changed Mortality Picture

      January 14, 2026

      Still Hot and Bothered?

      December 22, 2025

      Decoding Progress: The Evolution of Life Expectancy for Cancer Patients

      November 26, 2025

      Q&A: James Hadley, Senior Consultant, Barnett Waddingham

      November 26, 2025

      UK Equity Release Market Sees Double-Digit Growth in 2025

      January 28, 2026

      Equity Release Missing From Retirement Planning Conversations

      January 22, 2026

      Equity Release Council Promotes Kelly Melville-Kelly to Deputy CEO

      January 22, 2026

      AIR Asset Management’s Taylor Garvey Joins LISA Board, Promoted to Managing Director

      January 19, 2026

      UK Pension Risk Transfer Market Set to Hit £70bn in 2026

      February 10, 2026

      Deloitte UK Pension Schemes Completes Bulk Purchase Annuity Buy-In With Standard Life

      February 10, 2026

      Trustee of Vistry’s Final Salary Pension Schemes Completes Bulk Purchase Annuity Buy-In With PIC

      February 10, 2026

      The Argent Group Europe Pension Scheme Secures Full Scheme Bulk Purchase Annuity Buy-In With Just Group

      February 9, 2026
    • Events
    • Latest Issues

      Editor’s Letter – Volume 2, Issue 1, January 2026

      January 14, 2026

      Editor’s Letter – Volume 1, Issue 3, December 2025

      December 10, 2025

      Editor’s Letter – Volume 1, Issue 2, November 2025

      November 12, 2025

      Editor’s Letter – Volume 1, Issue 1, October 2025

      October 8, 2025

      Editor’s Letter – Volume 4, Issue 9, September 2025

      September 10, 2025
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    Q&A: Scott Willkomm, CEO, Life Equity, and Chair, European Life Settlement Association

    Secondary Life Markets January 11, 2023By Greg Winterton
    Life Risk News Q&A
    Share
    Twitter LinkedIn Email

    The European Life Settlement Association recently returned Life Equity CEO Scott Willkomm as Chair. Life Risk News’ Greg Winterton spoke to Willkomm to find out his views on the life settlement market generally and what 2023 has in store for ELSA.

    GW: Scott, let’s start with ELSA. What were some of the highlights of 2022 for the association?

    SW: I’d point to a couple of things. Firstly – and this isn’t quite specific to 2022 – is that in the last few years we have significantly increased our membership and industry engagement. ELSA’s membership has doubled since 2018; we’re now at 34. We want to position ELSA as the forum of choice for institutional investors looking at life-based secondary market investments for inclusion in their broader portfolios. Developing the code of practice and the master agreement for tertiary transactions are two endeavours that were designed to support that goal. We’re making good progress in involving institutions into the conversation now.

    Secondly, I think we’ve done a good job of demonstrating resilience and adaptability during the Covid-19 pandemic. Like everyone else, we adjusted to virtual events and communication; this was important as the pandemic highlighted the importance of understanding life risk amongst capital market participants and ELSA was able to demonstrate its strengths as a thought leader as well as provide a platform for discussion on the pandemic’s wider impact. The conferences we produce have continued to be some of the most sought after and best attended forums for networking in the life settlement industry, but we’ve also been expanding the audience with the life ILS event. Both of our conferences reach a broader universe and the fact that appetite amongst our members to return to in-person events this year validates what we’re trying to do in terms of both networking and education.

    Also, it would be amiss to not mention the launch of the Life Risk News publication as a highlight. The initiative behind the magazine was that we wanted to create a public forum for information dissemination not only in our space but more broadly with regards to life-linked investing. The first six months have been encouraging, and the magazine is hitting its stride now. We’re starting to do more in-depth discourse – topical discussions that are of interest to our membership and our readership.

    GW: What about some of the frustrations?

    SW: I’m not sure I’d use the word ‘frustrations’ but there are things where I’d like to see us get better. Historically, we haven’t really done much in the way of academic research and in-depth analytical content. And that’s important because not only can it provide additional insights to our members and the industry at large, but it adds credibility as well. So, what we’re doing now is the groundwork to launch a Research Committee which will take the lead on engaging with academics and that wider world to produce more in-depth, analytical content that we think will enable life settlements and broader life-based strategies to get a more consistent seat at the institutional investor table.

    Scott Willkomm

    In a similar vein – and again I wouldn’t call this a frustration, it’s simply another area where we want to improve – would be more discussion in Life Risk News about critical actions that are going on, and the real-world implications about valuing life risk. We’re getting there, though – the first six months of Life Risk News has been largely about producing more foundational content to educate the audience on the basics and now we’ll look to go to the next level in 2023.

    GW: Moving onto the life settlement market more generally now. From your perspective as a provider, as CEO of Life Equity, what trends emerged or changed in the market in 2022 and what was the impact on firms like Life Equity?

    SW: Something I’ve noticed this year is that while we’ve seen some new brokers enter the market, and some formerly active brokers re-engage with it, we haven’t seen the type of investment in market expansion from the broker side that I would have liked to see. Supply issues do plague the secondary market in the life settlement industry and even though there has been an uptick in deal activity in 2022, I think some of that is catching up from Covid-19. The brokers in the space tend to focus on higher value policies, which is understandable to a point, but there are plenty of policies that could turn into a life settlement that we never see because of this. I’m hopeful that as we begin the new year that more brokers in the industry expand the range of policies that they would consider.

    GW: In terms of 2023, will these trends continue, or were they short term aberrations, and what else is on your radar to keep an eye on more generally this year?

    SW: Obviously, with regards to the broker point I made, time will tell. In terms of other things on my radar, there are real business issues we, the life settlement industry, should be talking about and engaging with relevant groups. There is a lot of disparity in our industry in terms of stakeholder focus – there isn’t enough collaboration going on and all the constituent groups need to do better in terms of talking to each other and supporting each other to move our industry forward.

    GW: Finally, Scott, back to ELSA. What are some of the association’s goals for 2023? Is there anything new coming down the pipe?

    SW: The Research Committee is the new initiative we have. It will be finalised shortly and will begin planning probably before the end of the first half of this year. As I’ve already mentioned, getting Life Risk News to cruising altitude is another goal. I would hope that by the end of 2023, after 18 months of publishing, we’ll have gotten to that point where it’s a go-to place for the industry.

    One of the things about the life settlement industry is that it seems to struggle to find legitimacy or believe in its own legitimacy. It has a bit of an inferiority complex when compared to the reinsurance world, for example. The efforts on the Research Committee side and investing in and expanding Life Risk News will enable us to get a more permanent seat at the table. We have something to say, and not enough of the right people are hearing it at the moment; we’re confident these initiatives, added to our growing conference franchises, will help to solve for that challenge.

    Scott Willkomm is CEO of Life Equity and Chair of the European Life Settlement Association

    2023 - January Life Settlements Longevity Risk Q&A Volume 2 Issue 1 - January 2023
    Share. Twitter LinkedIn Email

    Related Posts

    UK Pension Risk Transfer Market Set to Hit £70bn in 2026

    February 10, 2026By LMI Newsdesk

    Deloitte UK Pension Schemes Completes Bulk Purchase Annuity Buy-In With Standard Life

    February 10, 2026By LMI Newsdesk

    Trustee of Vistry’s Final Salary Pension Schemes Completes Bulk Purchase Annuity Buy-In With PIC

    February 10, 2026By LMI Newsdesk

    The Argent Group Europe Pension Scheme Secures Full Scheme Bulk Purchase Annuity Buy-In With Just Group

    February 9, 2026By LMI Newsdesk
    Latest Issue

    Busy December in PHL Variable Life Insurance Company Saga but Is the End Now in Sight?

    January 14, 2026

    Will 2026 Be the Year That the US Agency-Backed Reverse Mortgage Market Finally Gets Its Well-Overdue Reform?

    January 14, 2026

    CMI Model Changes and Weight-Loss Drug Popularity Point to Changed Mortality Picture

    January 14, 2026

    Stability Continues in US Life Insurer Ownership and Solvency Metrics

    January 14, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from the Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.